- Pear Therapeutics ( NASDAQ: PEAR ) said that the California Department of Health Care Services (DHCS) had selected it to track and distribute incentives for the recovery incentives to treat Medi-Cal members with stimulant use disorder.
- The pilot program will allow eligible members, across 24 counties in California, to take part in a structured 24-week outpatient program that will be followed by at least six months of additional recovery support services.
- ( PEAR ) is trading ~4% higher premarket.
For further details see:
California Department of Health awards contract to Pear Therapeutics